Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ulrike, Mock"'
Autor:
Maciej J. Pelak, Birgit Flechl, Eugen Hug, Razvan Galalae, Lisa Konrath, Joanna Góra, Piero Fossati, Carola Lütgendorf-Caucig, Slavisa Tubin, Rastko Konstantinovic, Ulrike Mock, Christoph Fussl, Petra Georg
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AimData on the safety of moderately hypofractionated proton beam therapy (PBT) are limited. The aim of this study is to compare the acute toxicity and early quality of life (QoL) outcomes of normofractionated (nPBT) and hypofractionated PBT (hPBT).Ma
Externí odkaz:
https://doaj.org/article/74a9c62c6ea74555ae50b32301f2528d
Autor:
John R. Counsell, Guillaume De Brabandere, Rajvinder Karda, Marc Moore, Antonio Greco, Alysha Bray, Juan Antinao Diaz, Dany P. Perocheau, Ulrike Mock, Simon N. Waddington
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 357-365 (2021)
Lentiviral (LV) vectors based on human immunodeficiency virus type I (HIV-1) package two copies of their single-stranded RNA into vector particles. Normally, this RNA genome is reverse transcribed into a double-stranded DNA provirus that integrates i
Externí odkaz:
https://doaj.org/article/91dfe80765324ae6b172bc6c3bfd05e5
Autor:
Ulrike Mock, Juan Antinao Diaz, Simon N. Waddington, Dany P. Perocheau, Marc Moore, John R. Counsell, Rajvinder Karda, Antonio Greco, Alysha Bray, Guillaume De Brabandere
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 357-365 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Lentiviral (LV) vectors based on human immunodeficiency virus type I (HIV-1) package two copies of their single-stranded RNA into vector particles. Normally, this RNA genome is reverse transcribed into a double-stranded DNA provirus that integrates i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e910a9a483f9f9766f033b6ed683bb
https://doi.org/10.1016/j.omtm.2020.12.005
https://doi.org/10.1016/j.omtm.2020.12.005
Autor:
Slavisa Tubin, Piero Fossati, Ulrike Mock, Carola Lütgendorf-Caucig, Birgit Flechl, Maciej Pelak, Petra Georg, Christoph Fussl, Antonio Carlino, Markus Stock, Eugen Hug
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2093
Background: Skull base chordomas are radio-resistant tumors that require high-dose, high-precision radiotherapy, as can be delivered by particle therapy (protons and carbon ions). We performed a first clinical outcome analysis of particle therapy bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2656a993cb02460d7992c4b84613c927
https://doi.org/10.3390/cancers15072093
https://doi.org/10.3390/cancers15072093
Autor:
Eik Vettorazzi, Carsten Bokemeyer, Eva-Maria Grossjohann, Cedric Dos Santos, Ulrike Mock, Gabi Vohwinkel, Emily Latuske, Walter Fiedler, Jana Muschhammer, Roman Kischel, Dirk Nagorsen, Michael Heuser, Hauke Stamm, Felix Klingler, Michael Lutteropp, Felicitas Thol, Matthias Friedrich, Jasmin Wellbrock, Sabine Stienen
Publikováno v:
Oncogene
Immune checkpoints are promising targets in cancer therapy. Recently, poliovirus receptor (PVR) and poliovirus receptor-related 2 (PVRL2) have been identified as novel immune checkpoints. In this investigation we show that acute myeloid leukemia (AML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5231f23eb13c55277f1fb93ad1d825b1
http://europepmc.org/articles/PMC6160395
http://europepmc.org/articles/PMC6160395
Autor:
Olga S. Epifanovskaya, Kristoffer Riecken, Boris V. Afanasyev, Kirill V. Lepik, Gleb B. Sukhorukov, Alexander S. Timin, Ulrike Mock, Albert R. Muslimov, Vladislav S. Sergeev, Alena I. Shakirova, Maria V. Okilova, Boris Fehse
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 14:97-108
CRISPR-Cas9 is a revolutionary genome-editing technology that has enormous potential for the treatment of genetic diseases. However, the lack of efficient and safe, non-viral delivery systems has hindered its clinical application. Here, we report on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704f0c56529e3af6a7458cad01e40950
https://doi.org/10.1016/j.nano.2017.09.001
https://doi.org/10.1016/j.nano.2017.09.001
Autor:
Piero Fossati, L. Konrath, Petra Georg, M. Mumot, M. Sebek, Eugen B. Hug, C. Svardal, J. Zimmermann, Birgit Flechl, R. Konstantinovic, A. Schallerbauer-Peter, C. Lütgendorf-Caucig, M. Achtaewa, Ulrike Mock, M. Pelak
Publikováno v:
Radiotherapy and Oncology. 161:S49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a56e859237a1cce65700725ac74c0ea3
https://doi.org/10.1016/s0167-8140(21)06770-0
https://doi.org/10.1016/s0167-8140(21)06770-0
Autor:
Ulrike, Mock, Ramona, Mayer, Richard, Pötter, Robert, Jäger, Christian, Vutuc, Helmut, Eiter, Josef, Hammer, Robert, Hawliczek, Brigitte, Hirn, Tomas-Henrik, Knocke-Abulesz, Hans-Dieter, Kogelnik, Peter, Lukas, Elisabeth, Nechville, Brigitte, Pakisch, Michael, Papauschek, Wolfgang, Raunik, Walter, Rhomberg, Hubert, Sabitzer, Annemarie, Schratter-Sehn, Felix, Sedlmayer, Irene, Wedrich, Thomas, Auberger
Publikováno v:
In Radiotherapy and Oncology 2004 73 Supplement 2:S29-S34
Autor:
Ramona, Mayer, Ulrike, Mock, Robert, Jäger, Richard, Pötter, Christian, Vutuc, Helmut, Eiter, Kristine, Krugmann, Josef, Hammer, Brigitte, Hirn, Robert, Hawliczek, Tomas-Henrik, Knocke-Abulesz, Peter, Lukas, Elisabeth, Nechville, Brigitte, Pakisch, Michael, Papauschek, Wolfgang, Raunik, Walter, Rhomberg, Hubert, Sabitzer, Annemarie, Schratter-Sehn, Felix, Sedlmayer, Irene, Wedrich, Thomas, Auberger
Publikováno v:
In Radiotherapy and Oncology 2004 73 Supplement 2:S24-S28
Publikováno v:
JCI Insight. 3
T cells engineered to express chimeric antigen receptors (CARs) against B cell antigens are being investigated as cellular immunotherapies. Similar approaches designed to target T cell malignancies have been hampered by the critical issue of T-on-T c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb4c674e6d55aca4164b4de3f417ec5
https://doi.org/10.1172/jci.insight.99442
https://doi.org/10.1172/jci.insight.99442